Free triiodothyronine and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI

被引:9
作者
Chang, Xuewei [1 ,2 ]
Zhang, Shouyan [2 ]
Zhang, Mingming [2 ]
Wang, Hao [2 ]
Fan, Caifeng [2 ]
Gu, Yunfei [2 ]
Wei, Jinghan [1 ]
Qiu, Chunguang [1 ]
机构
[1] Zhengzhou Univ, Dept Cardiol, Affiliated Hosp 1, 1 Jianshe East Rd, Zhengzhou 450052, Peoples R China
[2] Zhengzhou Univ, Dept Cardiol, Luoyang Cent Hosp, Luoyang 471009, Henan, Peoples R China
来源
LIPIDS IN HEALTH AND DISEASE | 2018年 / 17卷
关键词
Myocardial infarction; Free triiodothyronine; Percutaneous coronary intervention; ELEVATION MYOCARDIAL-INFARCTION; NONTHYROIDAL ILLNESS SYNDROME; THYROID-HORMONE INACTIVATION; PARTICIPANT DATA-ANALYSIS; SUBCLINICAL HYPOTHYROIDISM; HEART-DISEASE; MORTALITY; SEVERITY; FAILURE; COHORT;
D O I
10.1186/s12944-018-0881-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The aim of this study is to investigate the combined value of fT3 and GRACE risk score for cardiovascular prognosis in ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods: Three hundred and thirty eight patients with STEMI who received successful primary PCI were enrolled in our study. All patients underwent (33.5 +/- 7.1) month's follow-up. Mace was defined as cardiac death and nonfatal myocardial infarction. Results: Multivariate Cox analysis showed that both fT3 (HR = 0.462, 95%CI: 0.364-0.587, P < 0.001) and GRACE score (HR = 1.011, 95%CI: 1.004-1.018, P = 0.003) were independent predictors of Mace. Similarly, fT3 (HR = 0.495, 95%CI: 0.355-0.690, P < 0.001) and GRACE score (HR = 1.022, 95%CI: 1.011-1.034, P < 0.001) were the most important independent predictors of cardiac death. Kaplan-Meier analysis revealed that those patients with low fT3 and higher GRACE score had higher rates of Mace (Log-Rank (X)2 = 25.087, P < 0.001). In ROC analysis, combining fT3 and GRACE risk score had a good area under the curve (AUC) value for Mace (AUC = 0.735, 95% CI: 0.680-0.790, P < 0.001), with net reclassification index of 11.1 and 5.3%, respectively. Conclusion: The low fT3 level, a common phenomenon, is a strong predictor of long-term poor prognosis in STEMI patients who underwent primary PCI. The combination of GRACE score and fT3 may be a more valuable predictor of Mace as compared to each measure alone.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome
    Pavasini, Rita
    Fabbri, Gioele
    Marchini, Federico
    Bianchi, Nicola
    Deserio, Maria Angela
    Sanguettoli, Federico
    Verardi, Filippo Maria
    Segala, Daniela
    Pompei, Graziella
    Tonet, Elisabetta
    Serenelli, Matteo
    Caglioni, Serena
    Guardigli, Gabriele
    Campo, Gianluca
    Cultrera, Rosario
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [32] The Clinical Value of the Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy Score in Predicting Long-Term Major Adverse Cardiovascular And Cerebrovascular Events and Major Bleeding in Acute Coronary Syndrome Patients Who Underwent Percutaneous Coronary Intervention
    Celik, Aykan
    Esin, Fatma Kayalti
    Emren, Sadik Volkan
    Kiris, Tuncay
    Karaca, Mustafa
    ANGIOLOGY, 2023, 74 (10) : 958 - 969
  • [33] Predictive Value of Endocan Based on TIMI Risk Score on Major Adverse Cardiovascular Events After Acute Coronary Syndrome
    Ziaee, Mojtaba
    Mashayekhi, Sina
    Ghaffari, Samad
    Mahmoudi, Javad
    Sarbakhsh, Parvin
    Garjani, Alireza
    ANGIOLOGY, 2019, 70 (10) : 952 - 959
  • [34] Long-term risk of major adverse cardiovascular events following ischemic stroke or TIA
    Carlsson, Andreas
    Irewall, Anna-Lotta
    Graipe, Anna
    Ulvenstam, Anders
    Mooe, Thomas
    oegren, Joachim
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [35] Predicting outcome in patients with acute coronary syndrome: Evaluation of B-type natriuretic peptide and the global registry of acute coronary events (GRACE) risk score
    Sinclair, H.
    Paterson, M.
    Walker, S.
    Beckett, G.
    Fox, K. A. A.
    SCOTTISH MEDICAL JOURNAL, 2007, 52 (03) : 8 - 13
  • [36] Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome
    Baluja, Aurora
    Rodriguez-Manero, Moises
    Cordero, Alberto
    Kreidieh, Bahij
    Iglesias-Alvarez, Diego
    Garcia-Acuna, Jose M.
    Martinez-Gomez, Alvaro
    Agra-Bermejo, Rosa
    Alvarez-Rodriguez, Leyre
    Abou-Jokh, Charigan
    Lopez-Raton, Monica
    Gude-Sampedro, Francisco
    Alvarez-Escudero, Julian
    Gonzalez-Juanatey, Jose R.
    DIABETES & VASCULAR DISEASE RESEARCH, 2020, 17 (01)
  • [37] Association between education and major adverse cardiac events among patients with acute coronary syndrome in the Arabian Gulf
    Al-Zakwani, Ibrahim
    Mabry, Ruth M.
    Zubaid, Mohammad
    Alsheikh-Ali, Alawi A.
    Almahmeed, Wael
    Shehab, Abdullah
    Rashed, Wafa
    BMJ GLOBAL HEALTH, 2019, 4 (01):
  • [38] Out-of-hospital cardiac arrest in patients treated with primary PCI for STEMI. Long-term follow up data from EUROTRANSFER registry
    Siudak, Zbigniew
    Birkemeyer, Ralf
    Dziewierz, Artur
    Rakowski, Tomasz
    Zmudka, Krzysztof
    Dubiel, Jacek S.
    Dudek, Dariusz
    RESUSCITATION, 2012, 83 (03) : 303 - 306
  • [39] Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention
    Liu, Xiao-Jun
    Wan, Zhao-Fei
    Zhao, Na
    Zhang, Ya-Ping
    Mi, Lan
    Wang, Xin-Hong
    Zhou, Dong
    Wu, Yan
    Yuan, Zu-Yi
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [40] Prognostic role of the left ventricular global function index in predicting major adverse cardiovascular events in acute coronary syndrome patients
    Doganay, Birsen
    Celebi, Ozlem Ozcan
    BIOMARKERS IN MEDICINE, 2023, 17 (01) : 5 - 16